We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICH DRAFT GUIDANCE ON PHARMACOVIGILANCE RELEASED BY FDA
ICH DRAFT GUIDANCE ON PHARMACOVIGILANCE RELEASED BY FDA
March 29, 2004
The FDA has issued a pharmacovigilance draft guidance that provides the foundation for a critical component of early postmarketing activities conducted by drug manufacturers, according to industry experts.